Cite
HARVARD Citation
Demiraslan, H. et al. (2017). Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. Medical mycology. pp. 535-540. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Demiraslan, H. et al. (2017). Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. Medical mycology. pp. 535-540. [Online].